Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study
LUTS: Lower Urinary Tract Symptoms · 2024-01 · 16 (1)
DOI: 10.1111/luts.12509 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 03.01.2024. Verfasst von Mehdi Shirazi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Lower Urinary Tract Symptoms, Pentoxifylline, Prostatic Hyperplasia, Urinary Bladder Neck Obstruction. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Background
In older adults, bladder outlet obstruction (BOO) is prevalent, primarily due to benign prostatic hyperplasia (BPH). These patients' lower urinary tract symptoms can be treated surgically and with medical therapy. Compared to standard treatment with tamsulosin, Pentoxifylline, a phosphodiesterase inhibitor, could benefit patients with BOO due to its properties on microcirculatory blood flow and oxygenation of ischemic tissues. Hence, this trial intended to study the efficacy of Pentoxifylline combined with tamsulosin in treating BOO patients. Materials and Methods This randomized, double‐blind clinical trial recruited 60 patients with BPH from a single center in 2022. Upon consent of patients meeting the eligibility criteria, they were randomly allocated to intervention (Pentoxifylline + tamsulosin) and control (placebo + tamsulosin) groups. The patients were evaluated for international prostate symptom score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max ) by uroflowmetry, and post‐void residual volume (PVR) by abdominal sonography at the onset of the study and after the 12th week.
Results
Patients who used the combination therapy had significantly better results of prostate symptoms and quality of life improvement (IPSS: −36.6%, QoL: −45.3%) compared to patients who received tamsulosin alone (IPSS: −21.2%, QoL: −27.7%) ( p < .001). Also, this study shows that the improvement in maximum urinary flow rate and residual volume by combination therapy is significantly higher (Q max : +42.5%, PVR: −42.6%) compared to monotherapy (Q max : +25.1%, PVR: −26.1%) ( p < .001).
Conclusion
When combined with tamsulosin, Pentoxifylline could significantly improve the lower urinary symptoms of BPH patients. It is well tolerated, and the treatment outcomes are better in patients who receive the combination of Pentoxifylline and tamsulosin than those who only receive tamsulosin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Zahra Jahanabadi
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Shirazi, M., Dehghanmanshadi, A., Sadr, S., & Jahanabadi, Z. (2024). Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study. LUTS: Lower Urinary Tract Symptoms, 16(1). https://doi.org/10.1111/luts.12509
Vancouver
Shirazi M, Dehghanmanshadi A, Sadr S, Jahanabadi Z. Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study. LUTS: Lower Urinary Tract Symptoms. 2024;16(1). doi:10.1111/luts.12509
BibTeX
@article{Shirazi2024,
author = {Shirazi, Mehdi and Dehghanmanshadi, Alireza and Sadr, Soroush and Jahanabadi, Zahra},
title = {Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2024},
volume = {16},
number = {1},
doi = {10.1111/luts.12509}
}
EUVIMED